Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF/VI vs FF in Persistent Asthma
NCT01686633Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2012
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
A Phase 3 trial of fluticasone, vilanterol in asthma, sponsored by GSK. Started Sep 2012; status: completed.
02
Drugs
fluticasonevilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01686633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01686633.